Give me a realistic case presentation with all the values for a patient with ureteric calculus Selina bibi 32 years female right ureteric calculus Date of admission- 1/7/ 26 CECT SCAN OF KUB:- Procedure- CECT Oof KUB region through simply sis pubis by taking 5mm ; thin contagious parallel slices FINDINGS: Kidney- mild fullness is notes in right renal collecting sytem Ureter- rt ureter is mildly prominent with a partially obstructing raidodense calculus (+1244 HU; 7M9×6.5×15.0mm)noted in right mid ureter at the level of L4 Vertebrae. Another small radioDense calculus (+606 HU ; 4m0×2.0mm) is suggested in intramural part of right terminal ureter

Reading File
Finding Sources
Searching the Web

ureteric calculus case presentation clinical findings lab values investigation

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Excellent - I have thorough clinical content. Now I have everything needed to construct a fully realistic, detailed case presentation. Let me build it comprehensively.

Case Presentation: Right Ureteric Calculus


PATIENT DETAILS

NameSelina Bibi
Age / Sex32 years / Female
IP No.2026-07-001
Date of Admission01 / 07 / 2026
ConsultantDr. _____________
WardUrology / Surgery
OccupationHomemaker
Address_____________

CHIEF COMPLAINTS

  1. Severe colicky pain in the right loin radiating to the right iliac fossa and right labium majus - 3 days
  2. Nausea and vomiting - 3 days
  3. Burning micturition and increased frequency of urination - 1 day
  4. Haematuria (gross, painless terminal) - 1 day

HISTORY OF PRESENT ILLNESS

Selina Bibi, a 32-year-old female, was apparently well until 3 days prior to admission when she developed sudden onset severe, colicky pain in the right loin. The pain radiated to the right iliac fossa, right groin, right labium majus, and the anteromedial aspect of the right thigh, consistent with referral along the genitofemoral nerve. The pain was griping in character, intermittent (colicky), of high intensity, causing her to roll restlessly on the bed (unable to find a comfortable position). It was accompanied by profuse sweating, nausea, and multiple episodes of vomiting. There was no prior history of similar episodes.
Over the last 24 hours, she additionally developed:
  • Burning micturition and urinary urgency/frequency (suggesting the lower calculus entering the intramural ureter)
  • Terminal gross haematuria
  • Strangury (painful, incomplete voiding)
No fever, no dysuria prior to 24 hours, no significant weight loss. No previous renal/urinary tract surgery. No family history of urolithiasis.
Past History: No known hypertension, diabetes, or tuberculosis. No previous urological interventions.
Dietary History: Low fluid intake (~1L/day). High dietary oxalate intake (spinach, tomatoes). No excessive dairy.
Menstrual History: Regular cycles, LMP 15/06/2026. Not pregnant.
Drug History: No long-term medications. No calcium or vitamin D supplements.

GENERAL PHYSICAL EXAMINATION

ParameterFinding
General conditionModerately distressed, restless, writhing in pain
Built & NutritionAverage
ConsciousnessAlert and oriented
Temperature37.1°C (afebrile)
Pulse98 bpm, regular, good volume
Blood Pressure118/76 mmHg
Respiratory Rate18/min
SpO₂99% on room air
BMI23.4 kg/m²
PallorAbsent
IcterusAbsent
CyanosisAbsent
ClubbingAbsent
LymphadenopathyAbsent
OedemaAbsent

SYSTEMIC EXAMINATION

Abdomen

  • Inspection: Flat, moves with respiration; no visible peristalsis; no distension
  • Palpation: Mild tenderness along the course of the right ureter (right iliac fossa); no guarding or rigidity; right kidney not ballottable; no palpable mass
  • Right renal angle (CVA) tenderness: Present (right loin punch tenderness positive)
  • Left renal angle: Non-tender
  • Percussion: No dullness
  • Auscultation: Bowel sounds present and normal

Cardiovascular System

  • S1 S2 heard; no murmurs

Respiratory System

  • Bilateral air entry equal; no added sounds

Central Nervous System

  • Oriented to time, place, person; no focal deficits

Per Vaginal / Per Rectal Examination

  • Not performed at admission; deferred pending pain management
  • (Intramural ureteric stone may be palpable on PV/PR examination - planned post analgesia)

INVESTIGATIONS

A. HAEMATOLOGICAL

TestValueReference Range
Haemoglobin11.8 g/dL12.0-16.0 g/dL
Total WBC count10,200/mm³4,000-11,000/mm³
Neutrophils68%50-70%
Lymphocytes26%20-40%
Eosinophils3%1-6%
Monocytes3%2-8%
Platelets2.4 lakhs/mm³1.5-4.0 lakhs/mm³
ESR22 mm/hr (Westergren)< 20 mm/hr
MCV84 fL80-100 fL
MCH28 pg27-32 pg
MCHC32 g/dL32-36 g/dL

B. BIOCHEMISTRY

TestValueReference Range
Blood Urea28 mg/dL15-40 mg/dL
Serum Creatinine0.9 mg/dL0.5-1.1 mg/dL (female)
eGFR88 mL/min/1.73 m²> 60 mL/min/1.73 m²
Serum Sodium138 mEq/L135-145 mEq/L
Serum Potassium4.1 mEq/L3.5-5.0 mEq/L
Serum Chloride100 mEq/L96-106 mEq/L
Serum Bicarbonate24 mEq/L22-28 mEq/L
Blood Glucose (random)92 mg/dL< 200 mg/dL
Serum Calcium9.6 mg/dL8.5-10.5 mg/dL
Serum Phosphorus3.4 mg/dL2.5-4.5 mg/dL
Serum Uric Acid4.8 mg/dL2.4-6.0 mg/dL (female)
Total Protein7.2 g/dL6.4-8.3 g/dL
Albumin4.0 g/dL3.5-5.0 g/dL
ALT (SGPT)22 IU/L7-56 IU/L
AST (SGOT)20 IU/L10-40 IU/L
ALP78 IU/L44-147 IU/L
Total Bilirubin0.6 mg/dL0.2-1.2 mg/dL
CRP8.2 mg/L< 10 mg/L
PTH (intact)38 pg/mL15-65 pg/mL

C. URINALYSIS

TestValueReference Range
ColourPale yellow with slight turbidityYellow, clear
pH5.84.5-8.0
Specific Gravity1.0221.010-1.030
Protein+ (trace)Negative
GlucoseNegativeNegative
Blood / Haemoglobin+++ (gross haematuria)Negative
NitritesNegativeNegative
Leucocyte esterase+Negative
KetonesNegativeNegative
BilirubinNegativeNegative
Microscopy - RBC25-30/HPF0-2/HPF
Pus cells (WBC)4-6/HPF0-5/HPF
Epithelial cellsOccasionalOccasional
CastsNo RBC casts; occasional granular castsNone
CrystalsCalcium oxalate crystals (envelope-shaped) seenNone

D. URINE CULTURE & SENSITIVITY

  • Result: No growth (after 48 hours) - Sterile urine
  • (Repeat if fever develops)

E. URINE SPOT TESTS (24-hour Urine - collected post-stabilisation)

TestValueReference
24-hr Urine Volume1,050 mL/24 hr> 2,000 mL recommended
24-hr Urine Calcium310 mg/24 hr< 250 mg/24 hr (F) - hypercalciuria
24-hr Urine Oxalate48 mg/24 hr< 45 mg/24 hr - mild hyperoxaluria
24-hr Urine Uric Acid560 mg/24 hr< 750 mg/24 hr
24-hr Urine Citrate280 mg/24 hr> 320 mg/24 hr (F) - hypocitraturia
24-hr Urine Sodium182 mEq/24 hr100-200 mEq/24 hr
(Findings suggest combined hypercalciuria + mild hyperoxaluria + hypocitraturia as stone risk factors)

F. COAGULATION PROFILE

TestValueReference Range
PT12.4 sec11-13.5 sec
INR1.00.8-1.2
aPTT30 sec25-35 sec
Bleeding Time2 min1-3 min
Clotting Time6 min4-8 min

G. BLOOD GROUPING & Rh TYPING

  • Group: B Positive (B+)

H. SEROLOGY

  • HBsAg: Non-reactive
  • Anti-HCV: Non-reactive
  • HIV I & II: Non-reactive

IMAGING & SPECIAL INVESTIGATIONS

1. X-RAY KUB (Plain)

  • Radiodense shadow noted along the right ureter at the level of L4 vertebra
  • No calcification in the left urinary tract
  • Psoas shadow intact bilaterally
  • No bony abnormality

2. ULTRASOUND ABDOMEN & PELVIS (Preliminary)

  • Right Kidney: Mild pelvi-calyceal dilatation (Grade I hydronephrosis); renal cortex intact; no focal lesion
  • Right Ureter: Mildly dilated proximal ureter; distal to the stone - decompressed
  • Right Stone: Echogenic shadow with posterior acoustic shadowing in right mid-ureter
  • Left Kidney: Normal size (10.8 cm); no calculus; no hydronephrosis
  • Urinary Bladder: Adequately filled; no intraluminal lesion; bilateral ureteric jets visible on colour Doppler (right jet reduced)
  • Uterus and Ovaries: Normal

3. CECT SCAN KUB (CONTRAST-ENHANCED CT)

Referring Clinician's Request Fulfilled - Full report below:

CECT KUB - REPORT
Patient: Selina Bibi | Age/Sex: 32 yrs / Female Date of Study: 01/07/2026 Referring Consultant: Dr. ________________ Radiologist: Dr. ________________
Procedure: CECT of the KUB region was performed from the level of the dome of the diaphragm through the symphysis pubis using 5 mm thin contiguous parallel slices, following intravenous administration of 80 mL of non-ionic iodinated contrast (Iohexol 300 mg I/mL) with acquisition in the nephrographic and excretory phases. Non-contrast images were obtained first as per stone protocol.

FINDINGS:
KIDNEYS:
  • Right Kidney: Mild fullness / dilatation noted in the right renal collecting system (pelvi-calyceal system) consistent with early/mild hydronephrosis (Grade I). Renal parenchyma is preserved. No cortical thinning. Corticomedullary differentiation maintained. No focal renal lesion. No perinephric collection.
  • Left Kidney: Normal in size (left kidney 10.6 cm × 5.1 cm), shape, and position. No calculus. No hydronephrosis. Normal enhancement.
URETERS:
  • Right Ureter: Mildly prominent/dilated right ureter proximal to the site of calculus. A partially obstructing radiodense calculus (+1244 HU; 7.9 × 6.5 × 15.0 mm) is noted in the right mid-ureter at the level of the L4 vertebra. There is periureteric fat stranding noted around this calculus, suggesting an inflammatory response.
    • Additionally, another small radiodense calculus (+606 HU; 4.0 × 2.0 mm) is identified in the intramural part of the right terminal ureter (ureterovesical junction region).
  • The right ureter distal to the mid-ureteric calculus and proximal to the intramural stone appears decompressed.
  • Left Ureter: Normal calibre throughout. No filling defect or calculus.
URINARY BLADDER:
  • Adequate distension. Smooth walls. No intraluminal mass or calculus. No bladder wall thickening.
OTHER FINDINGS:
  • No retroperitoneal lymphadenopathy
  • No free fluid in abdomen/pelvis
  • Liver, gallbladder, spleen, pancreas, and visualised bowel loops appear unremarkable

IMPRESSION:
  1. Right mid-ureteric calculus (+1244 HU; 7.9 × 6.5 × 15.0 mm) at L4 vertebral level - partially obstructing with mild fullness of the right renal collecting system and periureteric fat stranding.
  2. Second small radiodense calculus (+606 HU; 4.0 × 2.0 mm) in the intramural part of the right terminal ureter (vesicoureteric junction).
  3. No features of complete obstruction or significant hydronephrosis at this time.
  4. No evidence of left-sided calculus or urinary tract pathology.
Radiologist's Comment: High HU value of the mid-ureteric calculus (+1244 HU) is consistent with a calcium oxalate or calcium phosphate stone. The smaller terminal stone at +606 HU may represent a uric acid or mixed composition stone.

DIAGNOSIS

Primary Diagnosis:

Right ureteric calculus - double stones:
  • Right mid-ureteric calculus (7.9 × 6.5 × 15.0 mm, +1244 HU) at L4 level - partially obstructing
  • Right intramural/terminal ureteric calculus (4.0 × 2.0 mm, +606 HU) with resultant:
  • Mild right hydronephrosis (Grade I)
  • Recurrent right ureteric colic
  • Haematuria (secondary)
  • Strangury (due to intramural calculus)

DIFFERENTIAL DIAGNOSES (Considered and excluded/kept)

ConditionSupportingAgainst
1Acute appendicitisRight-sided pain, mild leukocytosisNo peritoneal signs, pain colicky + haematuria, CECT no appendiceal changes
2Right ovarian pathology (torsion/cyst)Female, right-sided pelvic painUSG ovaries normal; CECT no ovarian lesion
3Right-sided UTI / pyelonephritisLeucocytes in urineNo fever, urine culture sterile, no renal parenchymal enhancement abnormality
4Ectopic pregnancyFemale, right-sided painLMP 15/6/26, urine beta-hCG negative, uterus normal on USG
(Urine beta-hCG was sent and returned negative)

TREATMENT PLAN

Immediate / Acute Management

InterventionDetails
1IV Access18G IV cannula inserted; IV fluids - Normal Saline 1L over 6 hours for hydration
2AnalgesiaInj. Diclofenac 75 mg IM stat (NSAID - reduces ureteral peristalsis and inflammation); Inj. Tramadol 50 mg IV as rescue analgesia
3AntiemeticInj. Ondansetron 4 mg IV TDS
4Alpha-blocker (MET)Tab. Tamsulosin 0.4 mg OD at night (medical expulsive therapy - relaxes distal ureteral smooth muscle, improves spontaneous passage rate from 54% to 77% per meta-analysis per Schwartz's Surgery)
5Urine strainingAll urine strained through gauze to capture passed calculus for composition analysis
6Fluid intakeEncouraged to maintain urinary output > 2 L/day
7MonitoringHourly urine output, 4-hourly vitals, daily renal function tests

Definitive Management Planning

Mid-ureteric stone (7.9 mm at L4): This is a larger stone (> 5 mm) with low probability of spontaneous passage. Options discussed:
OptionComment
Ureteroscopy + Laser Lithotripsy (URSL)Preferred for mid-ureteric stones > 5 mm; high success rate > 90%
Extracorporeal Shock Wave Lithotripsy (ESWL)Can be attempted for stones ≤ 10 mm, less effective for mid-ureteric stones
Laparoscopic ureterolithotomyReserved for failed endoscopic approach
Intramural terminal stone (4.0 mm): Small stone - good chance of spontaneous passage with MET (Tamsulosin). Watchful waiting appropriate.
Planned Procedure: Ureteroscopy (rigid/flexible) + Holmium:YAG laser lithotripsy of right mid-ureteric calculus under spinal anaesthesia, with Double-J (DJ) stent placement post-lithotripsy.

PRE-OPERATIVE WORKUP (for URSL)

TestResult
1HB/BT/CTDone (see above)
2ECGNormal sinus rhythm
3Chest X-Ray PA viewNo active cardiopulmonary pathology
4Urine C&SSterile - clearance given
5Anaesthesia fitnessObtained - fit for spinal anaesthesia
6Informed consentObtained (patient and attender)
7Pre-op fasting6 hours
8Pre-op antibioticInj. Ceftriaxone 1 g IV single dose 30 min pre-op

METABOLIC WORKUP & LONG-TERM PREVENTION

Based on 24-hr urine and biochemistry findings, the patient has:
  • Hypercalciuria (24-hr Ca 310 mg) - likely idiopathic
  • Mild hyperoxaluria (dietary) - high spinach intake
  • Hypocitraturia (citrate 280 mg/24 hr) - low urine pH aids stone formation
Prevention plan (post-discharge):
  1. Fluid intake > 2.5-3 L/day (target urine output > 2 L/day)
  2. Dietary restriction: Reduce oxalate-rich foods (spinach, nuts, tea, chocolate), reduce sodium intake
  3. Tab. Potassium Citrate 15 mEq TDS (alkalinises urine, increases citrate, inhibits crystallisation)
  4. Tab. Hydrochlorothiazide 25 mg OD if hypercalciuria persists
  5. Follow-up USG KUB at 1 month post-discharge
  6. Repeat 24-hr urine metabolic profile at 3 months

PROGNOSIS

  • The mid-ureteric stone requiring URSL has an excellent prognosis with > 90% stone-free rate following laser lithotripsy.
  • The small intramural stone has a high likelihood of spontaneous passage with MET.
  • Without metabolic correction and lifestyle change, the 5-year recurrence rate for calcium oxalate stones is ~50%.

NOTES

  • The CECT findings confirm the exact stone dimensions, Hounsfield units (HU values help predict stone composition and fragility for lithotripsy planning), and the degree of obstruction.
  • A stone of +1244 HU is consistent with calcium oxalate monohydrate (hard stone - Holmium laser preferred over ESWL).
  • The second stone at +606 HU may be uric acid-based (softer - amenable to dissolution therapy with urinary alkalinisation if needed).

Sources: S Das Manual of Clinical Surgery 13th Ed., p.587; Gray's Anatomy for Students; Schwartz's Principles of Surgery 11th Ed. (Urolithiasis); Campbell-Walsh-Wein Urology
This is a shared conversation. Sign in to Orris to start your own chat.